Figure 1. Business areas covered by 2012 public-private partnerships. Breakdown of therapeutic areas covered by public-private partnerships (PPPs; I) and seed or series A financings (III) in 2012. PPPs (II) and financings (IV) from 2011 are provided for comparison. For (I) and (II), percentages are out of the total number of PPPs worldwide; bracketed values are actual numbers. For (III) and (IV), percentages are out of total financing events across all therapeutic areas; bracketed values are the actual number of companies that received financing for a given therapeutic area. Data includes double counting because some partnerships and companies are tied to more than one business and/or disease area.